Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

PTH Infusion for Seizures in Autosomal Dominant Hypocalcemia Type 1.

Sastre A. et al, (2021), N Engl J Med, 385, 189 - 191

Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnany or menopause

Zhou J. et al, (2021), Nature Genetics

The bromodomain inhibitor JQ1+ reduces calcium-sensing receptor activity in pituitary cell-lines.

Lines KE. et al, (2021), J Mol Endocrinol

Multiple Endocrine Neoplasia Type 1 in Children and Adolescents: Clinical Features and Treatment Outcomes

SHARIQ O. and RICHARDS D., (2021), Surgery

Multiple Endocrine Neoplasia Type 1: Latest Insights.

Brandi ML. et al, (2021), Endocr Rev, 42, 133 - 170

Multiple Endocrine Neoplasia Type 1 (MEN1) Phenocopy Due to a Cell Cycle Division 73 (CDC73) Variant.

Lines KE. et al, (2020), J Endocr Soc, 4

Multiple endocrine neoplasia type 1 (MEN1) 5' UTR deletion, in MEN1 family, decreases menin expression.

Kooblall KG. et al, (2020), J Bone Miner Res

Whole genome sequence analysis identifies a PAX2 mutation to establish a correct diagnosis for a syndromic form of hyperuricemia.

Stevenson M. et al, (2020), Am J Med Genet A

Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs).

Grozinsky-Glasberg S. et al, (2020), Endocr Relat Cancer

Genetic background influences tumour development in heterozygous Men1 knockout mice.

Lines KE. et al, (2020), Endocr Connect, 9, 426 - 437

Clinical MEN-1 among a large cohort of patients with acromegaly.

Nachtigall LB. et al, (2020), J Clin Endocrinol Metab

MEN1-related PanNETs: identifying unmet clinical needs and future directives.

Pieterman CRC. et al, (2020), Endocr Relat Cancer

Effects of epigenetic pathway inhibitors on corticotroph tumour AtT20 cells

LINES K. et al, (2020), Endocrine-Related Cancer

Activating mutations of the G-protein subunit α11 interdomain interface cause autosomal dominant hypocalcemia type 2.

Gorvin CM. et al, (2019), J Clin Endocrinol Metab

Large-Scale Sequence Database Analyses Reveals 5 novel GNA11 mutations that alter Calcium-Sensing-Receptor Signalling: Relevance for FHH2 and ADH2

Gluck A. et al, (2019), JOURNAL OF BONE AND MINERAL RESEARCH, 34, 321 - 321

Large-Scale Sequence Database Analyses Reveals 5 novel GNA11 mutations that alter Calcium-Sensing-Receptor Signalling: Relevance for FHH2 and ADH2

Gluck A. et al, (2019), JOURNAL OF BONE AND MINERAL RESEARCH, 34, 321 - 321

Epigenetic dysregulation in pituitary tumors

Shariq OA. and Lines KE., (2019), International Journal of Endocrine Oncology

TWO SYNCHRONOUS PITUITARY ADENOMAS CAUSING CUSHING DISEASE AND ACROMEGALY.

Schorr M. et al, (2019), AACE Clin Case Rep, 5, e276 - e281

Association of prolactin receptor (PRLR) variants with prolactinomas.

Gorvin CM. et al, (2019), Hum Mol Genet, 28, 1023 - 1037

MiR-15a/miR-16-1 expression inversely correlates with cyclin D1 levels in Men1 pituitary NETs.

Lines KE. et al, (2018), J Endocrinol

Load More

Include forthcoming?